Hong He

3.1k total citations
91 papers, 2.4k citations indexed

About

Hong He is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Hong He has authored 91 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 37 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Hong He's work include Pancreatic and Hepatic Oncology Research (19 papers), Cancer-related Molecular Pathways (19 papers) and Protein Kinase Regulation and GTPase Signaling (10 papers). Hong He is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), Cancer-related Molecular Pathways (19 papers) and Protein Kinase Regulation and GTPase Signaling (10 papers). Hong He collaborates with scholars based in Australia, China and United States. Hong He's co-authors include Graham S. Baldwin, Hiroshi Maruta, Mehrdad Nikfarjam, Nhi Huynh, Arthur Shulkes, Tadaomi Takenawa, Kiyohito Mizutani, Hiroaki Miki, Patricia W. Finn and Kevin H. Liu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hong He

88 papers receiving 2.4k citations

Peers

Hong He

ONCOL

IMMUN

Michael Schnoor Mexico

Charles C. King United States

Mary Ann Suico Japan

Amos Baruch United States

Colleen Fearns United States

Eiko Sakai Japan

Liliane Gattegno France

Ja Seok Koo United States

Yongchang Qiu United States

Susan A. Brooks United Kingdom

Michael Schnoor Mexico

Hong He

1.2k ×1.0

307 ×0.4

ONCOL

709 ×1.7

IMMUN

358 ×1.0

192 ×0.8

Citations per year, relative to Hong He Hong He (= 1×) peers Michael Schnoor

Countries citing papers authored by Hong He

Since Specialization

Citations

This map shows the geographic impact of Hong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong He more than expected).

Fields of papers citing papers by Hong He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong He. The network helps show where Hong He may publish in the future.

Co-authorship network of co-authors of Hong He

This figure shows the co-authorship network connecting the top 25 collaborators of Hong He. A scholar is included among the top collaborators of Hong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong He. Hong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nikfarjam, Mehrdad, et al.. (2023). PAK in Pancreatic Cancer-Associated Vasculature: Implications for Therapeutic Response. Cells. 12(23). 2692–2692. 5 indexed citations

Xiao, Meng, David S. Perlin, Yanan Zhao, et al.. (2022). Decreased echinocandin susceptibility in Candida parapsilosis causing candidemia and emergence of a pan-echinocandin resistant case in China. Emerging Microbes & Infections. 12(1). 37 indexed citations

Zhu, Xiaojia, Xudong Peng, Jing Lin, et al.. (2021). Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis. International Immunopharmacology. 96. 107785–107785. 17 indexed citations

Maruta, Hiroshi & Hong He. (2020). PAK1-blockers: Potential Therapeutics against COVID-19. SHILAP Revista de lepidopterología. 6. 100039–100039. 87 indexed citations

He, Hong, et al.. (2019). Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer. SHILAP Revista de lepidopterología. 5(1). 1–7. 37 indexed citations

Wang, Kai, Graham S. Baldwin, Mehrdad Nikfarjam, & Hong He. (2019). Antitumor effects of all-trans retinoic acid and its synergism with gemcitabine are associated with downregulation of p21-activated kinases in pancreatic cancer. American Journal of Physiology-Gastrointestinal and Liver Physiology. 316(5). G632–G640. 16 indexed citations

Wang, Kai, Yifan Zhan, Nhi Huynh, et al.. (2019). Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1. Cancer Letters. 472. 8–18. 36 indexed citations

Lee, N., Mehrdad Nikfarjam, & Hong He. (2018). Functions of the CXC ligand family in the pancreatic tumor microenvironment. Pancreatology. 18(7). 705–716. 34 indexed citations

Yeo, Dannel, Hong He, Graham S. Baldwin, & Mehrdad Nikfarjam. (2015). P-038 FRAX597, a PAK1 inhibitor, synergises with gemcitabine in the reduction of pancreatic cancer growth. Annals of Oncology. 26. iv10–iv10. 2 indexed citations

10.

Huynh, Nhi, John A. Beutler, Arthur Shulkes, Graham S. Baldwin, & Hong He. (2014). Glaucarubinone inhibits colorectal cancer growth by suppression of hypoxia-inducible factor 1α and β-catenin via a p-21 activated kinase 1-dependent pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(1). 157–165. 19 indexed citations

11.

Nikfarjam, Mehrdad, Dannel Yeo, Hong He, et al.. (2013). Comparison of Two Syngeneic Orthotopic Murine Models of Pancreatic Adenocarcinoma. Journal of Investigative Surgery. 26(6). 352–359. 12 indexed citations

12.

He, Hong & Graham S. Baldwin. (2012). p21-activated kinases and gastrointestinal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(1). 33–39. 20 indexed citations

13.

He, Hong, Nhi Huynh, Kevin H. Liu, et al.. (2011). P-21 activated kinase 1 knockdown inhibits β-catenin signalling and blocks colorectal cancer growth. Cancer Letters. 317(1). 65–71. 47 indexed citations

14.

Huynh, Nhi, Kevin H. Liu, Graham S. Baldwin, & Hong He. (2010). P21-activated kinase 1 stimulates colon cancer cell growth and migration/invasion via ERK- and AKT-dependent pathways. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1803(9). 1106–1113. 86 indexed citations

15.

He, Hong, Arthur Shulkes, & Graham S. Baldwin. (2008). PAK1 interacts with β-catenin and is required for the regulation of the β-catenin signalling pathway by gastrins. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1783(10). 1943–1954. 54 indexed citations

16.

He, Hong & Graham S. Baldwin. (2008). Rho GTPases and p21-activated kinase in the regulation of proliferation and apoptosis by gastrins. The International Journal of Biochemistry & Cell Biology. 40(10). 2018–2022. 7 indexed citations

17.

He, Hong, et al.. (2005). Glycine-extended gastrin stimulates cell proliferation and migration through a Rho- and ROCK-dependent pathway, not a Rac/Cdc42-dependent pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology. 289(3). G478–G488. 23 indexed citations

18.

Gao, Tianwen, Chunying Li, Hong He, et al.. (2004). [Retrospective analysis of 1905 patients with skin cancer from two general hospitals in western China from 1981 to 2000].. PubMed. 36(5). 469–72. 10 indexed citations

19.

He, Hong, Yumiko Hirokawa, Aviv Gazit, et al.. (2004). The Tyr-Kinase Inhibitor AG879, that Blocks the ETK-PAK1 Interaction, Suppresses the RAS-induced PAK1 Activation and Malignant Transformation. Cancer Biology & Therapy. 3(1). 96–101. 31 indexed citations

20.

Maruta, Hiroshi, Hong He, & Thao Nheu. (2003). Interfering with Ras Signaling Using Membrane-Permeable Peptides or Drugs. Humana Press eBooks. 189. 75–85. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact